Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
| Locations: China Read more: #clinicaltrials #clinicalresearch #patientrecruitment #clinicalmetric To view or add a comment, sign in Basic Learning Topics on BE Study 1
weeks 912 reach 1.0 mg
Source: The New England Journal of Medicine Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff et al., 2022) Figure 1A Average Weight Loss After 72 Weeks At 72 weeks, participants taking tirzepatide once weekly lost significantly more weight than those on placebo: 5 mg dose: 15.0% average body weight reduction 10 mg dose: 19.5% reduction 15 mg dose: 20.9% reduction Placebo: 3.1% reduction All tirzepatide doses showed much greater weight loss compared to placebo
Dimitriou, P.C
Instead, they decided to own the distribution
Several firms that initially covered GLP-1s for weight loss have since restricted coverage to specific medical indications like diabetes
US$ 26.39
US$ 24.16
US$ 23.46
US$ 23.30
US$ 24.82
US$ 20.24
US$ 24.27
US$ 26.44
